Answer
Yes, Tavlesse (fostamatinib) can increase blood pressure, including causing hypertension, in patients with immune thrombocytopenia; patients with pre-existing hypertension may be more susceptible.
Sources for this answer
- Tavlesse 100 mg film-coated tabletsGrifols UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked